Company intelligence / Profile preview
ACO
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
Overview
ACO (Apotekens Composita) is a leading Nordic skincare and pharmaceutical company founded in 1939 in Sweden. Originally established by the Swedish Pharmaceutical Society to provide quality-assured pharmacy products, the company specializes in scientifically developed dermacosmetics and medicinal skincare solutions tailored for the Nordic climate. Its extensive portfolio includes well-known brands such as ACO, Cosmica, Cliniderm, and Miniderm, which address a wide range of needs from daily face and body care to specialized treatments for acne, eczema, and sun protection. ACO operates its own research and development laboratory, focusing on pure, carefully selected ingredients with proven efficacy and safety. In 2025, Karo Healthcare announced the acquisition of ACO from Perrigo, a strategic move that enhances its presence in the European consumer healthcare market.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculeTopical formulation
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on ACO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACO.